1. PACK Cross-Linking as Adjuvant Therapy Improves Clinical Outcomes in Culture-Confirmed Bacterial Keratitis
- Author
-
Omar Elhaddad, Boris Knyazer, Yonit Krakauer, Asaf Achiron, Tamir Regev, Farhad Hafezi, and Erez Tsumi
- Subjects
medicine.medical_specialty ,Multivariate analysis ,Microbiological culture ,Visual acuity ,Ultraviolet Rays ,medicine.drug_class ,Riboflavin ,Antibiotics ,Eye Infections, Bacterial ,law.invention ,law ,Internal medicine ,medicine ,Adjuvant therapy ,Humans ,Keratitis ,Photosensitizing Agents ,business.industry ,computer.file_format ,Confidence interval ,Anti-Bacterial Agents ,Ophthalmology ,Cross-Linking Reagents ,Gram staining ,Photochemotherapy ,Collagen ,medicine.symptom ,ABX test ,business ,computer - Abstract
PURPOSE We recently showed the positive clinical effects of combining accelerated corneal cross-linking (PACK-CXL) with antibiotic treatment in patients with presumed bacterial keratitis. In this study, we compare the impacts of a combined PACK-CXL/standard antibiotic treatment (PACK-ABX group) with standard antibiotic treatment alone (ABX group) in patients with culture-confirmed bacterial keratitis. METHODS We reviewed patients with moderate and severe bacterial keratitis and confirmed bacterial cultures. Clinical outcomes were compared for standard antibiotic treatment alone, before the initiation of PACK-CXL, and after adjuvant use of PACK-CXL. RESULTS A total of 47 eyes of 47 patients were included: 26 eyes in the PACK-ABX group and 21 eyes in the ABX group. Pathogens, baseline demographics (besides age), and clinical parameters were similar between the 2 groups. The PACK-ABX patients had better final uncorrected visual acuity [mean difference 0.57 Logarithm of the Minimum Angle of Resolution, 95% Confidence Interval (CI): 0.16-0.99, P = 0.07] and best-corrected visual acuity (mean difference 0.70 Logarithm of the Minimum Angle of Resolution, 95% CI: 0.23-1.16, P = 0.04), shorter reepithelialization time (mean difference 9.63 days, 95% CI: 3.14-16.12, P = 0.004), and reduced number of clinic visits (mean difference 4.8 meetings, 95% CI: 1.4-8.2, P = 0.007) and need for tectonic grafts (0 vs. 33.3%, P = 0.002). A multivariate analysis controlling for age, sex, ulcer size, and Gram stain showed that PACK-ABX treatment remained significantly associated with reepithelialization time (β = 14.5, P = 0.001). CONCLUSIONS In our study, PACK-CXLs addition to the standard of care in cases of culture-proven bacterial keratitis had a positive effect on the final visual acuity and time to resolution, compared with the standard-of-care treatment.
- Published
- 2021